Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:ALTH

Allos Therapeutics (ALTH) Stock Price, News & Analysis

Allos Therapeutics logo

About Allos Therapeutics Stock (NASDAQ:ALTH)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
N/A
Average Volume
N/A
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive ALTH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Allos Therapeutics and its competitors with MarketBeat's FREE daily newsletter.

ALTH Stock News Headlines

See More Headlines

ALTH Stock Analysis - Frequently Asked Questions

Based on aggregate information from My MarketBeat watchlists, some other companies that Allos Therapeutics investors own include E-House (China) Holdings Limite (EJ), DryShips (DRYS), Depomed (DEPO), Hongli Clean Energy Technologie (CETC), (CASC) (CASC), Biostar Pharmaceuticals (BSPM) and Alexco Resource (AXU).

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
N/A
Industry
N/A
Sub-Industry
N/A
Current Symbol
NASDAQ:ALTH
CIK
1097264
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
N/A
Quick Ratio
N/A

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
N/A
Price / Book
N/A

Miscellaneous

Outstanding Shares
N/A
Free Float
N/A
Market Cap
N/A
Optionable
Not Optionable
Beta
N/A
5G Stocks: The Path Forward is Profitable Cover

Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report

This page (NASDAQ:ALTH) was last updated on 7/13/2025 by MarketBeat.com Staff
From Our Partners